Insider Trading June 9, 2026 05:43 PM

Nina Capital Holdings Acquires Additional Stake in PetMed Express Amid Market Decline

Ten percent shareholder increases position by $43,725 as PETS stock faces significant downward pressure following missed earnings expectations.

By Derek Hwang
Share
Twitter Reddit Facebook LinkedIn
PETS

Nina Capital Holdings Inc., a ten percent owner of PetMed Express Inc. (NASDAQ:PETS), has purchased an additional $43,725 worth of common stock. The acquisition occurred on June 8, 2026, involving 25,000 shares at a weighted average price of $1.749 per share. This purchase comes as the stock has experienced substantial declines over recent periods, trading near its 52-week low. The acquisition follows a challenging earnings report for PetMed Express, which missed both earnings per share and revenue forecasts for Q4 2026.

Nina Capital Holdings Acquires Additional Stake in PetMed Express Amid Market Decline
PETS
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Nina Capital Holdings Inc. acquired 25,000 shares of PetMed Express common stock on June 8, 2026, at a weighted average price of $1.749 per share.
  • The acquisition brings the total holdings of reporting owners to 2,600,000 shares, with Nina Capital Holdings Inc. holding 1,875,000 shares and Moises Tache Galante and Stephannie Matz Zyman holding 725,000 shares jointly.
  • PetMed Express reported Q4 2026 earnings that missed both EPS and revenue forecasts, with EPS at -$0.19 versus expected -$0.13 and revenue at $42.8 million versus expected $52 million.

Nina Capital Holdings Inc., a ten percent owner of PetMed Express Inc. (NASDAQ:PETS), has acquired an additional $43,725 worth of common stock. The transaction was executed on June 8, 2026, involving 25,000 shares at a weighted average price of $1.749 per share. The shares were acquired through multiple transactions with prices ranging from $1.72 to $1.75, inclusive. This activity is notable as the stock has declined 19.7% over the past week and trades down 58.5% over the past year. According to InvestingPro analysis, PETS appears undervalued at current levels, with the stock trading near its 52-week low of $1.57. InvestingPro offers exclusive Fair Value analysis and 10 additional ProTips for PETS, plus comprehensive Pro Research Reports covering over 1,400 US equities.

Following this acquisition, the reporting owners collectively hold 2,600,000 shares of common stock. This total includes 1,875,000 shares held by Nina Capital Holdings Inc. and 725,000 shares held jointly by Moises Tache Galante and his spouse, Stephannie Matz Zyman. Moises Tache Galante and Stephannie Matz Zyman are also listed as ten percent owners of the company.

In other recent news, PetMed Express reported its Q4 2026 earnings, revealing a challenging financial landscape as the company missed both earnings per share (EPS) and revenue forecasts. The reported EPS was -$0.19, falling short of the expected -$0.13, which resulted in a 46.15% negative surprise. Revenue was reported at $42.8 million, significantly below the $52 million forecast, marking a 17.69% shortfall. These results indicate a difficult quarter for the company, as reflected in the market’s reaction. Analysts and investors are closely monitoring these developments, given the substantial discrepancies from the expected figures. The recent earnings report has raised concerns among stakeholders about the company’s financial health.

Risks

  • PetMed Express missed both earnings per share and revenue forecasts for Q4 2026, indicating a challenging financial landscape.
  • The stock has declined 19.7% over the past week and 58.5% over the past year, trading near its 52-week low of $1.57.
  • Analysts and investors are closely monitoring developments due to substantial discrepancies from expected figures, raising concerns about the company’s financial health.

More from Insider Trading

Silver Lake Affiliates Divest Dell Technologies Shares Amid Valuation Analysis Jun 9, 2026 Silver Lake Reduces Dell Holdings as AI Demand Drives Analyst Upgrades Jun 9, 2026 Westwood Holdings Director Emerita Byrne Sells Shares Under Pre-Arranged Plan Jun 9, 2026 Impinj Director Affiliated With Sylebra Capital Offloads $5.89 Million in Shares Amid Stock Correction Jun 9, 2026 ANI Pharmaceuticals CFO Stephen Carey Executes Option Exercise and Sale Under Pre-Adopted Trading Plan Jun 9, 2026